v3.26.1
Asset acquisition and short-term investment – related party (Details Narrative) - USD ($)
3 Months Ended 6 Months Ended
Sep. 29, 2025
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Jun. 12, 2026
Dec. 31, 2025
Asset Acquisition [Line Items]              
Share price           $ 0.94  
Issuance of common share       $ 348,702    
Equity method loss   $ 87,545 179,126    
Short term investments   $ 4,503,973   $ 4,503,973     $ 4,683,099
Telomir Pharmaceuticals Inc [Member]              
Asset Acquisition [Line Items]              
Equity method investment ownership percentage   5.00%   5.00%     10.00%
Telomir Pharmaceuticals Inc [Member]              
Asset Acquisition [Line Items]              
Issuance of acquisition 3,521,127            
Issuance of acquisition $ 5,000,000            
Share price $ 1.42            
SKNY Pharmaceuticals Inc [Member]              
Asset Acquisition [Line Items]              
Share price $ 1.34            
Issuance of common share $ 4,718,310